IL135987A0 - Lysozyme analogous proteins and peptides, processes for the preparation thereof and compositions and methods utilizing the same - Google Patents

Lysozyme analogous proteins and peptides, processes for the preparation thereof and compositions and methods utilizing the same

Info

Publication number
IL135987A0
IL135987A0 IL13598798A IL13598798A IL135987A0 IL 135987 A0 IL135987 A0 IL 135987A0 IL 13598798 A IL13598798 A IL 13598798A IL 13598798 A IL13598798 A IL 13598798A IL 135987 A0 IL135987 A0 IL 135987A0
Authority
IL
Israel
Prior art keywords
lysozyme
peptides
compositions
processes
preparation
Prior art date
Application number
IL13598798A
Other languages
English (en)
Original Assignee
Mpb Cologne Gmbh Molecular Pla
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mpb Cologne Gmbh Molecular Pla filed Critical Mpb Cologne Gmbh Molecular Pla
Publication of IL135987A0 publication Critical patent/IL135987A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462—Lysozyme (3.2.1.17)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8281—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for bacterial resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8282—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for fungal resistance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
IL13598798A 1997-11-05 1998-10-31 Lysozyme analogous proteins and peptides, processes for the preparation thereof and compositions and methods utilizing the same IL135987A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19749973A DE19749973C1 (de) 1997-11-05 1997-11-05 Lysozym-analoge Proteine und Peptide mit antimikrobieller Wirkung, ihre Herstellung und ihre Verwendung
PCT/DE1998/003287 WO1999024589A2 (fr) 1997-11-05 1998-10-31 Proteines et peptides analogues au lysozyme et a action antimicrobienne, leur production et leur utilisation

Publications (1)

Publication Number Publication Date
IL135987A0 true IL135987A0 (en) 2001-05-20

Family

ID=7848391

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13598798A IL135987A0 (en) 1997-11-05 1998-10-31 Lysozyme analogous proteins and peptides, processes for the preparation thereof and compositions and methods utilizing the same

Country Status (9)

Country Link
US (1) US6515106B1 (fr)
EP (1) EP1029061A2 (fr)
JP (1) JP2002503443A (fr)
AU (1) AU751422B2 (fr)
CA (1) CA2308618A1 (fr)
DE (1) DE19749973C1 (fr)
IL (1) IL135987A0 (fr)
NZ (1) NZ504368A (fr)
WO (1) WO1999024589A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19749973C1 (de) * 1997-11-05 1998-10-22 Klaus Dr Duering Lysozym-analoge Proteine und Peptide mit antimikrobieller Wirkung, ihre Herstellung und ihre Verwendung
ES2405848T3 (es) * 2003-12-23 2013-06-04 Biokit S.A. Composiciones y métodos para detección de infección patógena

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0155190A3 (fr) * 1984-03-16 1987-08-19 Genentech, Inc. Zymogènes inexistant dans la nature et procédé et matières pour leur préparation
IT1190433B (it) * 1985-12-11 1988-02-16 Prodotti Antibiotici Spa Peptidi correlati al lisozima
WO1989004371A1 (fr) * 1987-11-02 1989-05-18 Louisiana State University Agricultural And Mechan Plantes ameliorees genetiquement pour resister aux maladies
ATE189231T1 (de) * 1989-04-10 2000-02-15 Helix Biomedix Inc Lytische peptide, verwendung als wachstumsfördernde mittel und für infektionen und krebs
DE3926390A1 (de) * 1989-08-10 1991-02-14 Bayer Ag Verwendung von lysozym genen in pflanzen zur resistenzerhoehung
US5422108A (en) * 1991-09-19 1995-06-06 Smart Plants International Inc. Protection of plants against plant pathogens
US5607914A (en) * 1993-01-13 1997-03-04 Pioneer Hi-Bred International, Inc. Synthetic antimicrobial peptides
DE19749973C1 (de) * 1997-11-05 1998-10-22 Klaus Dr Duering Lysozym-analoge Proteine und Peptide mit antimikrobieller Wirkung, ihre Herstellung und ihre Verwendung

Also Published As

Publication number Publication date
NZ504368A (en) 2002-11-26
AU1867999A (en) 1999-05-31
WO1999024589B1 (fr) 2000-02-03
US6515106B1 (en) 2003-02-04
WO1999024589A2 (fr) 1999-05-20
EP1029061A2 (fr) 2000-08-23
JP2002503443A (ja) 2002-02-05
AU751422B2 (en) 2002-08-15
CA2308618A1 (fr) 1999-05-20
DE19749973C1 (de) 1998-10-22
WO1999024589A3 (fr) 1999-11-04

Similar Documents

Publication Publication Date Title
AU1226297A (en) Basic protein composition, basic peptide composition and application thereof
AUPN999096A0 (en) Peptides, antibodies, vaccines & uses thereof
GB9807256D0 (en) Functional protein compositions,emulsions based thereon and processes for their preparation
AU739516C (en) Novel lantibiotic related to actagardine, and processes for the preparation and use thereof
AU5031598A (en) Immune-modulation with amino acids
AU9105698A (en) Rab proteins
AU1999999A (en) Contryphan peptides
GB9700154D0 (en) Peptides
IL135987A0 (en) Lysozyme analogous proteins and peptides, processes for the preparation thereof and compositions and methods utilizing the same
GB2336844B (en) Anti-hiv peptides and proteins
AU6275098A (en) Novel h-rev 107-like protein
EP0996457A4 (fr) Peptides liberateurs de f.s.h.
IL145233A0 (en) Recombinant plant proteins and methods utilizing the same
GB2311783B (en) Polypeptides derived from wasp protein
AU3338195A (en) Allergen peptides
AU1038899A (en) Transfecting peptide vector, composition containing same and applications
AU6040598A (en) Blnk proteins
GB9604865D0 (en) Modified proteins
AU1506599A (en) Novel protein
GB9403263D0 (en) Novel opiod peptides
AU7555298A (en) Method for preparing peptides
GB2311067B (en) Proline rich peptides derived from the rasgap-associated protein P62
AU6340998A (en) Permuted hemoglobin-like proteins
AU721149C (en) Method for stabilizing peptide and peptide-containing lyophilized pharmaceutical composition using the method
AU9280798A (en) Process for freeze-drying proteins